Table 2.
Variable | N(%) (n = 416) |
PF | RP | BP | GH | VT | SF | RE | MH |
---|---|---|---|---|---|---|---|---|---|
Gender | |||||||||
Male | 159 (38.22%) | 93.52 (12.15) | 69.30 (39.62) | 73.48 (20.52) | 61.86 (20.63) | 61.10 (17.59) | 77.43 (19.58) | 46.96 (43.45) | 61.43 (17.29) |
Female | 257 (61.78%) | 93.23 (8.72) | 70.43 (37.71) | 71.42 (19.74) | 58.70 (19.01) | 61.46 (16.66) | 78.99 (16.88) | 41.89 (42.75) | 60.33 (16.91) |
Major | |||||||||
Clinical medicine (eight-year programme) in the 4th year | 75 (18.03%) | 92.07 (11.69) | 61.24 b (43.05) | 70.35 a (18.61) | 56.71 a (20.58) | 56.93 a (16.25) | 77.19 a (18.17) | 40.44 (42.90) | 57.87 a (18.59) |
Clinical medicine (five-year programme) in the 4th year | 92 (22.12%) | 94.08 (7.98) | 68.48 (38.31) | 73.49 (19.43) | 59.85 (20.62) | 61.03 (15.17) | 79.59 (18.07) | 44.93 (44.87) | 60.61 (15.39) |
Preventive medicine in the 4th year | 85 (20.43%) | 91.76 (14.88) | 72.35 (38.77) | 77.11 (20.00) | 62.11 (18.07) | 63.94 (17.85) | 78.82 (15.68) | 47.06 (42.82) | 63.53 (15.61) |
Oral medicine in the 4th year | 81 (19.47%) | 94.32 (7.15) | 78.40 (35.30) | 71.72 (20.74) | 66.47 (16.65) | 65.93 (15.43) | 82.03 (15.87) | 50.62 (43.82) | 65.73 (14.35) |
Clinical medicine (five-year programme) in the 3rd year | 83 (19.95%) | 94.34 (6.71) | 68.98 (35.48) | 67.92 (20.56) | 54.22 (20.30) | 58.43 (18.87) | 74.16 (20.98) | 35.74 (39.91) | 55.81 (19.49) |
Total | 416 (100%) | 93.34 (10.16) | 70.00 (38.41) | 72.20 (20.04) | 59.91 (19.68) | 61.32 (17.00) | 78.39 (17.96) | 43.83 (43.04) | 60.75 (17.04) |
a One-way ANOVA, p < 0.1; b Kruskal-Wallis test, p < 0.1.